All drugs can cause side effects. Some of these are more common, and may go away after a few days. Others are more serious and can require medical care. You should consider all side effects when deciding if a drug may work for you.
Ocella and Yasmin also have similar serious side effects, which are uncommon in healthy women. These serious side effects include:. An interaction is when a substance changes the way a drug works. This can be harmful or prevent the drug from working well. Ocella and Yasmin interact with other drugs in the same way. For example, both Ocella and Yasmin can increase the amount of potassium in your body. So, taking other drugs that also increase potassium could raise your potassium level to an unhealthy range.
Other interaction effects are possible. Examples of drugs that may interact with Ocella or Yasmin include:. Your overall health is a factor when you and your doctor are considering if a drug is a good choice for you. For instance, if you have a certain condition or disease, a particular drug may make it worse. Ocella and Yasmin would have the same effects on any medical conditions you may have. Both pills can be used safely in many women. However, you should avoid them in some cases. If you have a history of depression, talk with your doctor to see if Ocella or Yasmin is safe for you.
If your doctor prescribes you one of these birth control pills, watch your symptoms. If your depression comes back or gets worse, stop taking the pill and call your doctor.
General recommendations for missed doses: If one dose is missed, the patient should take it as soon as she remembers and then take the next pill at the regular time as usual. It may be necessary to take 2 tablets in one day.
Some manufacturers recommend that a second method of non-hormonal contraception be used for at least 7 days after restarting the pills. If two doses in a row are missed, 2 tablets should be taken on both the day the missed doses are remembered and the following day. The regular schedule should then be continued. A second method of non-hormonal contraception should be used for at least 7 days after restarting the pills. Recommendations for restarting the pills can be found in the patient information leaflet that accompanies the prescription each time it is filled.
A second method of contraception should be used for at least 7 days after the pills are restarted. Gianvi : - Store at controlled room temperature between 68 and 77 degrees F Jasmiel: - Store at controlled room temperature between 68 and 77 degrees F Loryna: - Store at controlled room temperature between 68 and 77 degrees F Lo-Zumandimine: - Store at controlled room temperature between 68 and 77 degrees F Nikki Day: - Store at controlled room temperature between 68 and 77 degrees F Ocella : - Store at controlled room temperature between 68 and 77 degrees F Syeda : - Store at controlled room temperature between 68 and 77 degrees F Vestura: - Store at controlled room temperature between 68 and 77 degrees F Yasmin: - Store at controlled room temperature between 68 and 77 degrees F Yaz: - Store at controlled room temperature between 68 and 77 degrees F Zarah : - Store at controlled room temperature between 68 and 77 degrees F Zumandimine: - Store at controlled room temperature between 68 and 77 degrees F.
Use of drospirenone; ethinyl estradiol, as with other contraceptive steroids, may result in clinical changes that influence the results of certain laboratory tests, such as coagulation factors, lipids, glucose tolerance, and binding proteins. Specific laboratory test interference has not been reported. Drospirenone; ethinyl estradiol does not protect against human immunodeficiency virus HIV infection or other sexually transmitted disease.
Conversely, patients with known HIV infection or acquired immunodeficiency syndrome AIDS should be aware that the use of combined oral hormonal contraceptives COCs will not prevent the transmission of HIV or other diseases to their partner s.
Drospirenone has antimineralocorticoid activity and may increase serum potassium. Because of the antimineralocorticoid activity, drospirenone may predispose certain patients to hyperkalemia or impaired adrenal function; thus drospirenone; ethinyl estradiol is contraindicated in patients with renal impairment i. The use of potassium-sparing medications or strong CYP3A4 inhibitors concurrently with drospirenone may predispose to this electrolyte imbalance; females taking such medications should have their potassium level checked during the first treatment cycle with drospirenone; ethinyl estradiol, and as clinically indicated thereafter.
Surgery can increase the risk for thromboembolism from combined hormonal contraceptives. If feasible, discontinue drospirenone; ethinyl estradiol products at least 4 weeks before and through 2 weeks after major surgery or other surgeries known to have an elevated risk of thromboembolism, and during and following any prolonged immobilization.
Because of the increased potential for embolic risk, combined oral contraceptives COCs containing drospirenone; ethinyl estradiol are contraindicated in women who currently have diabetes mellitus and are over 35 years of age, diabetes mellitus with hypertension or with vascular disease or end-organ damage, or diabetes mellitus of greater than 20 years duration.
Patients with diabetes mellitus should be observed for changes in glucose tolerance when initiating or discontinuing estrogen therapy, since estrogen therapy may exacerbate diabetes. Altered glucose tolerance secondary to decreased insulin sensitivity has been reported. Women who are being treated for dyslipidemia should be followed closely if they elect to use oral contraceptives.
Some progestogens may elevate LDL levels and may render the control of hyperlipidemia more difficult. Females with hypertriglyceridemia, or a family history thereof, may be at an increased risk of pancreatitis when using COCs.
Drospirenone; ethinyl estradiol products are contraindicated in patients with migraine or other headache that is accompanied by focal neurological symptoms, such as aura, or women over age 35 with any migraine headaches.
COCs may cause an exacerbation of migraine or a change in headache patterns and should be used with caution in women with migraine. Patients who complain of migraine with focal neurologic visual changes should be medically evaluated, and in some patients, such changes may indicate cerebrovascular events.
Consistent with potential thrombotic effects of combined oral hormonal contraceptives COCs , there have been clinical case reports of retinal thrombosis with COC use. The COC should be discontinued if there is unexplained visual disturbance, partial or complete loss of vision, onset of proptosis or diplopia, papilledema, or retinal vascular lesions. Appropriate diagnostic and therapeutic measures should be undertaken immediately.
Estrogens can increase the curvature of the cornea; patients using contact lenses wearers who develop visual changes or changes in lens tolerance should be assessed by an ophthalmologist. Drospirenone; ethinyl estradiol products are contraindicated in patients with hypersensitivity to any of the product components. Ethinyl estradiol is generally contraindicated in patients who have a history of anaphylaxis or history of angioedema to the drug.
Cases of both anaphylactic reactions and angioedema have been reported in patients taking estrogens. Events have developed in minutes and have required emergency medical treatment. Exogenous estrogens may induce or exacerbate symptoms of angioedema, particularly in women with hereditary angioedema, which may be hormonally sensitive. Given the increased prevalence of hypercoagulable states in patients with systemic lupus erythematosus SLE in particular antiphospholipid antibodies and lupus anticoagulant and the risk factors for thromboembolism, consider risks vs.
Avoid COC use in SLE patients with a history of venous or arterial thrombosis or the presence of a hypercoagulable state. Combined hormonal oral contraceptive COC use has also been reported to induce, unmask, or exacerbate SLE; more data are needed. Discontinue drospirenone; ethinyl estradiol if pregnancy is detected; there is no reason to continue combined oral hormonal contraceptives COCs during pregnancy.
Epidemiologic studies and meta-analyses have not found an increased risk of genital or nongenital birth defects including cardiac anomalies and limb-reduction defects following exposure to COCs before conception or during early pregnancy.
For any patient who has missed two consecutive periods, pregnancy should be ruled out. If the patient has not adhered to the prescribed COC schedule, consider the possibility of pregnancy at the first missed period.
Discontinue COC use if pregnancy is confirmed. Manufacturers recommend avoidance of combined hormonal oral contraceptives COCs if possible during breast-feeding until a mother has completely weaned her child. After oral administration, roughly 0. In terms of pricing, Yasmin is more expensive than Ocella. Both tablets are taken for 28 days for once a day. If a woman misses a dose, she should take it as soon as she remembers. If she misses it again, she should take two pills at the same time.
If she forgets for the third time, she should already stop it and use another form of contraception. She can resume the pills the next cycle of the month. Contraindications of these tablets include women who are smoking and are beyond 35 years old as this increases the risk for stroke and heart disease.
They are also not being given to those with uncontrolled hypertension. Women with elevated triglycerides are not being prescribed this medication. Women should also report and stop using this drug if jaundice occurs as this indicates liver toxicity. My last period lasted for days.
I should start my period on March 11th. I have not missed any pills, and I do have unprotected sex. But on Yaz there were no side effects and all my cysts were gone.
But remember, everyone is different. Hope this was helpful! She would take Tylenol, and eventually the headache would go away. At the time we did not make the relation between headaches and birth control pills. After taking Tylenol and sleeping a few hours, she woke up, still didn't feel right and laid back down.
I been on Ocella for almost 2 months. They hurt if I touch them, run or make any fast move. I did get my period which it was not that heavy being that I hadnt had a period for over a year.
Could that be the problem? I switched birth control from Ocella generic of Yaz to Loestrin 24 fe, and I've read side effects that say vaginal irritation is a possibility beacause of reduced estrogen. I've changed soaps 5 times, everything from Summers Eve to tear free hypoallergenic kids soap. Is there a connection between thyroid cysts and indigestion? Anxiety and Panic. Is there any difference in the contraception effectiveness of Yaz in patients with polycystic ovarian syndrome?
If so what are they? My question is, could YAz and Topamax at mg, be taken together? Is there a difference between a complex nodule and a complex cystic nodule? I know complex means both solid and cystic. My friend's ultrasound call it a complex cystic nodule.
It is unusual for it to act that fast but Yaz can have the side effect of lightening or stopping the period all together but from what I understand it is after at least a month but your body may react differently to the medication a doctors opinion would be the best advice. I have been on yaz for a year and I have noticed that since then I have been suffering from anxiety, panic attacks and depression. This is not like me at all and have even gone to the point of therapy.
A major side effect of the pill is depression and I know this is what is causing this.
0コメント